Association of VKORC1 -1639 G>A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 94, Issue 2, 2011, Pages 236-241

  Tavridou, Anna ^a   Petridis, Ioannis ^b   Vasileiadis, Michail ^c   Ragia, Georgia ^a   Heliopoulos, Ioannis ^a   Vargemezis, Vassileios ^a   Manolopoulos, Vangelis G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Academic General Hospital Alexandroupolis   (Greece)

^c Hospital Papageorgiou   (Greece)

Author keywords

Atherosclerosis; Calcification; Carotid intima media thickness; Type 2 diabetes mellitus; VKORC1 1639 G>A polymorphism

Indexed keywords

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RISK FACTOR; VKORC1 GENE;

AGED; ANALYSIS OF VARIANCE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GREECE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; VASCULAR CALCIFICATION;

EID: 81255136994     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.06.021     Document Type: Article

References (43)

1. Mintz G.S., Pichard A.D., Popma J.J., Kent K.M., Satler L.F., Bucher T.A., et al. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol 1997, 29:268-274.
2. Greenland P., LaBree L., Azen S.P., Doherty T.M., Detrano R.C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004, 291:210-215.
3. Kondos G.T., Hoff J.A., Sevrukov A., Daviglus M.L., Garside D.B., Devries S.S., et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003, 107:2571-2576.
4. Chironi G., Simon A., Denarie N., Vedie B., Sene V., Megnien J.L., et al. Determinants of progression of coronary artery calcifications in asymptomatic men at high cardiovascular risk. Angiology 2002, 53:677-683.
5. Schmermund A., Baumgart D., Mohlenkamp S., Kriener P., Pump H., Gronemeyer D., et al. Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler Thromb Vasc Biol 2001, 21:421-426.
6. Wong N.D., Kawakubo M., LaBree L., Azen S.P., Xiang M., Detrano R. Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines. Am J Cardiol 2004, 94:431-436.
7. Benton J.L., Ding J., Tsai M.Y., Shea S., Rotter J.I., Burke G.L., et al. Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 193:352-360.
8. Hernandez-Romero D., Ruiz-Nodar J.M., Marin F., Tello-Montoliu A., Roldan V., Mainar L., et al. CALU A29809G polymorphism in coronary atherothrombosis: implications for coronary calcification and prognosis. Ann Med 2010, 42:439-446.
9. Nemoto M., Nishimura R., Sasaki T., Hiki Y., Miyashita Y., Nishioka M., et al. Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc Diabetol 2007, 6:23.
10. Pollanen P.J., Lehtimaki T., Ilveskoski E., Mikkelsson J., Kajander O.A., Laippala P., et al. Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study. Atherosclerosis 2002, 164:329-335.
11. Valdes A.M., Wolfe M.L., O'Brien E.J., Spurr N.K., Gefter W., Rut A., et al. Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification. Arterioscler Thromb Vasc Biol 2002, 22:1924-1928.
12. Burdon K.P., Langefeld C.D., Beck S.R., Wagenknecht L.E., Carr J.J., Rich S.S., et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J 2006, 151:706-711.
13. McGeachie M., Ramoni R.L., Mychaleckyj J.C., Furie K.L., Dreyfuss J.M., Liu Y., et al. Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation 2009, 120:2448-2454.
14. Johnson R.C., Leopold J.A., Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006, 99:1044-1059.
15. Lehto S., Niskanen L., Suhonen M., Ronnemaa T., Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16:978-983.
16. Niskanen L., Siitonen O., Suhonen M., Uusitupa M.I. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care 1994, 17:1252-1256.
17. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol 2008, 3:1599-1605.
18. Edmonds M.E. Medial arterial calcification and diabetes mellitus. Z Kardiol 2000, 89(Suppl. 2):101-104.
19. Berkner K.L. Vitamin K-dependent carboxylation. Vitam Horm 2008, 78:131-156.
20. Li T., Chang C.Y., Jin D.Y., Lin P.J., Khvorova A., Stafford D.W. Identification of the gene for vitamin K epoxide reductase. Nature 2004, 427:541-544.
21. Manolopoulos V.G., Ragia G., Tavridou A. Pharmacogenetics of coumarinic oral anticoagulants. Pharmacogenomics 2010, 11:493-496.
22. Herrmann S.M., Whatling C., Brand E., Nicaud V., Gariepy J., Simon A., et al. Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 2000, 20:2386-2393.
23. Levy R.J., Gundberg C., Scheinman R. The identification of the vitamin K-dependent bone protein osteocalcin as one of the gamma-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves. Atherosclerosis 1983, 46:49-56.
24. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
25. Price P.A., Faus S.A., Williamson M.K. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998, 18:1400-1407.
26. Wang Y., Zhang W., Zhang Y., Yang Y., Sun L., Hu S., et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 2006, 113:1615-1621.
27. Teichert M., Visser L.E., van Schaik R.H., Hofman A., Uitterlinden A.G., De Smet P.A., et al. Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2008, 28:771-776.
28. Yuan H.Y., Chen J.J., Lee M.T., Wung J.C., Chen Y.F., Charng M.J., et al. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum Mol Genet 2005, 14:1745-1751.
29. Iordanidou M., Tavridou A., Petridis I., Arvanitidis K.I., Christakidis D., Vargemezis V., et al. The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes. Clin Chim Acta 2010, 411:167-171.
30. Ragia G., Petridis I., Tavridou A., Christakidis D., Manolopoulos V.G. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. Pharmacogenomics 2009, 10:1781-1787.
31. Sconce E.A., Khan T.I., Wynne H.A., Avery P., Monkhouse L., King B.P., et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood 2005, 106:2329-2333.
32. Weir B.S. Disequilibrium. Genetic data analysis II 1996, Sinaur Associates, Sunderland, MA, pp. 91-139.
33. Gauderman W.J., Morrison J.M. QUANTO 1. 1: A computer program for power and sample size calculations for genetic-epidemiology studies 2006, http://hydra.usc.edu/gxe.
34. Markatos C.N., Grouzi E., Politou M., Gialeraki A., Merkouri E., Panagou I., et al. VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients. Pharmacogenomics 2008, 9:1631-1638.
35. Geisen C., Watzka M., Sittinger K., Steffens M., Daugela L., Seifried E., et al. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost 2005, 94:773-779.
36. Stepien E., Branicka A., Ciesla-Dul M., Undas A. A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists. J Appl Genet 2009, 50:399-403.
37. Arnold M.L., Lichy C., Werner I., Radbruch A., Wagner S., Grond-Ginsbach C. Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German population. Thromb Haemost 2008, 100:614-617.
38. Watzka M., Nebel A., El Mokhtari N.E., Ivandic B., Muller J., Schreiber S., et al. Functional promoter polymorphism in the VKORC1 gene is no major genetic determinant for coronary heart disease in Northern Germans. Thromb Haemost 2007, 97:998-1002.
39. Wadwa R.P. Noninvasive measures of cardiovascular changes in diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2007, 14:263-268.
40. Arad Y., Spadaro L.A., Roth M., Scordo J., Goodman K., Sherman S., et al. Correlations between vascular calcification and atherosclerosis: a comparative electron beam CT study of the coronary and carotid arteries. J Comput Assist Tomogr 1998, 22:207-211.
41. Barrett-Connor E., Laughlin G.A., Connor C. Coronary artery calcium versus intima-media thickness as a measure of cardiovascular disease among asymptomatic adults (from the Rancho Bernardo Study). Am J Cardiol 2007, 99:227-231.
42. Taylor A.J., Bindeman J., Le T.P., Bauer K., Byrd C., Feuerstein I.M., et al. Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness. Atherosclerosis 2008, 197:339-345.
43. Wagenknecht L.E., Langefeld C.D., Carr J.J., Riley W., Freedman B.I., Moossavi S., et al. Race-specific relationships between coronary and carotid artery calcification and carotid intimal medial thickness. Stroke 2004, 35:e97-e99.